Case Study

Rapid Characterization Of Impurities

Source: Cambrex

By Darryl A. LeBlanc, PhD, Principal Scientist, Analytical Services, Cambrex

scientist lab test tube pipette iStock-1323987020

Impurities in drug products can arise at various time points during the manufacturing process or during storage. Without swift identification to assess potential risk, they can stall critical clinical timelines or cause a product recall. Understanding the nature of an impurity is a critical first step in determining whether the substance is recognized as a high-risk genotoxic impurity, a low-risk trace elemental impurity, or an unknown contaminant. However, identifying impurities can be complex, because they often surface as unknown peaks in a routine chromatogram. Their chemical nature can include both organic and inorganic molecules, and they can originate from multiple sources including starting materials, reaction intermediates and side products, or degradants.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online